Informations générales (source: ClinicalTrials.gov)
Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma
Interventional
Phase 2
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
septembre 2004
29 juin 2024
Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as
consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma
treated by surgery and a total of 6 cycles of platinum based chemotherapy.
A second look operation is performed after treatment; during this second look secondary
cytoreductive surgery is accepted without bowel resection.If none or milimetric
peritoneal disease is obseved an intraperitoneal chemotherapy is achieve
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CLCC INSTITUT GUSTAVE ROUSSY | Dominique ELIAS, MD,PhD | Contact (sur clinicalTrials) |
Critères
Femme
Inclusion Criteria:
epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy
-
epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy
-
- Patients ASA 3 patients with no residual tumor at first operation negative
microscopic second look